BTSG

Brightspring Health Services, Inc. Health Care Services-Home Health Care Services Russell 3000

$66.89Close $12.9BMarket cap $31.36 – $72.9152-week range Jan 29, 2027Next report · estimated

Stage 2 Leader 56th of 68

Highlights

Strengths

In a stage-2 uptrend all 8 trend conditions pass
Leading the market RS 91 · stronger than 91% of stocks over 12 months
Earnings growing EPS +78% year on year

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 30, 2026

Off 12-month high 8%

1wk 11.3% price change

1mo 17.9% price change

12-month return 104% market up 11% · its own up 86%

F-score 7 / 9 Strong

Altman Z″ 1.78 Moderate risk

P/E 68.0× price / earnings

PEG 0.10 P/E / EPS growth

P/B 6.9× price / book

Earnings yield 1.9% EBIT / enterprise value

Cheaper than 36% of the market · expensive

Revenue growth 28% year on year

EPS growth 78% latest quarter · -116 pts

Sales growth 26% latest quarter · +3 pts

ROE 11% return on equity

Free cash margin 3% $394.7M FCF

D/E 1.31 long-term debt / equity

Net debt / EBITDA 5.2×

Interest cover 1.9×EBIT / interest

Piotroski tests

issued more shares
gross margin narrowed
profitable on its assets
generating cash from operations
profitability improving
profits backed by cash
reduced long-term debt
short-term liquidity improved
assets working harder

Repair signals

FCF turned positive ($-57M → $395M)

Trade setup

ATR% 3.8% $2.54 a day · 2×ATR $61.80

RS 91 / 99 vs the universe

Trend 8 / 8 trend template

Relative volume 2.6× vs 50-day average

Up/down volume 1.49 50 sessions

Implied move — no scheduled report

Trend template · 8 of 8

Screen verdict

1 of 3 screens

Stage 2 Leader in mixed conditions
- RS 91
- Trend 8/8
- Off 12-month high 8%
- EPS growth +78% (accel -116 pts)
- Sales growth +26% (accel +3 pts)
- Altman Z″ 1.78 (moderate risk)

Warning signs

3 flagged

Interest is covered, but thinly Earnings before interest cover the interest bill 1.9 times, leaving little room if profits fall.
Heavily indebted Net debt is 5.2 times EBITDA — roughly 5 years of earnings before interest, tax and depreciation to repay borrowings in full.
Shareholders diluted The share count rose 10.3% over the year, from 174m to 192m shares. Each existing share owns a smaller fraction of the company than it did a year ago.

Last reported Oct 30, 2026

Results reaction Oct 30, 2026+13% vs market2 sessions after results

Financials

4 fiscal years · from filings

Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $12.9B +28% on FY2024

Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $189.1M +822% on FY2024

Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $394.7M back to a profit

Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology

Gross 12%
Net 1%
Free cash 3%

Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $2.4B net debt

Cash
Long-term debt

Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 192.12m

	FY2022Dec 31, 2022	FY2023Dec 31, 2023	FY2024Dec 31, 2024	FY2025Dec 31, 2025
Revenue	$6.6B	$7.7B	$10.1B	$12.9B
Gross margin	16%	15%	13%	12%
Operating income	$118.9M	$58.1M	$108.0M	$295.3M
Net income	-$53.9M	-$154.6M	$20.5M	$189.1M
Net margin	-1%	-2%	0%	1%
Earnings per share	-$0.46	-$1.31	$0.11	$0.86
Free cash flow	-$74.8M	$137.3M	-$57.1M	$394.7M
Free cash margin	-1%	2%	-1%	3%
Cash	$13.2M	$12.4M	$61.0M	$88.4M
Long-term debt	—	$3.3B	$2.6B	$2.5B
Shareholders' equity	$754.8M	$584.7M	$1.6B	$1.9B
Shares outstanding	—	117.86m	174.25m	192.12m

Filings

SEC EDGAR

Filed	Report	Period to	Lag
Oct 30, 2026	Quarterly ↗	Sep 30, 2026	30d
Jul 31, 2026	Quarterly ↗	Jun 30, 2026	31d
May 1, 2026	Quarterly ↗	Mar 31, 2026	31d
Feb 27, 2026	Annual ↗	Dec 31, 2025	58d
Oct 28, 2025	Quarterly ↗	Sep 30, 2025	28d
Aug 1, 2025	Quarterly ↗	Jun 30, 2025	32d
May 2, 2025	Quarterly ↗	Mar 31, 2025	32d
Mar 6, 2025	Annual ↗	Dec 31, 2024	65d
Nov 1, 2024	Quarterly ↗	Sep 30, 2024	32d
Aug 2, 2024	Quarterly ↗	Jun 30, 2024	33d
May 2, 2024	Quarterly ↗	Mar 31, 2024	32d

Current reports

Filed	Disclosed
Oct 30, 2026	Results ↗
Jul 31, 2026	Results ↗
Jun 12, 2026	Director or officer change · Regulation FD ↗
Jun 5, 2026	Material agreement ↗
May 21, 2026	Shareholder vote ↗
May 1, 2026	Results ↗
Mar 31, 2026	Acquisition or disposal · Director or officer change · Regulation FD ↗
Mar 4, 2026	Material agreement ↗
Feb 27, 2026	Results ↗
Oct 28, 2025	Results ↗
Oct 22, 2025	Material agreement ↗
Oct 20, 2025	Results ↗